Delivery Order SPE2DB22D2206-SPE2DB25FEF35

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 1.7 mg/0.75 ml pens. The contract has a ceiling value of $1,487.85 and a period of performance through May 7, 2025. This delivery order contract is priced on a firm-fixed-price basis and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 2.4 mg/0.75 ml pens. The firm-fixed-price delivery order has a ceiling value of $4,621.43 and an ultimate completion date of July 31, 2024. The contract does not have a set-aside designation. As a large indefinite delivery contract (IDC) holder with the DLA Troop Support Medical, valued up to $999,999,999, AmerisourceBergen is...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML medical products. The contract has a ceiling value of $72,836.79 and a completion date of January 28, 2025. The contract is a delivery order with a firm fixed price pricing type. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of WEGOVY 1.7 mg/0.75 ml pens, valued at $3,589.95, with a completion date of March 20, 2025. The contract has a firm-fixed-price pricing type and is not associated with any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,190.00, is for the delivery of WEGOVY 0.5 mg/0.5 ml pens. The contract is a firm fixed price delivery order with a completion date of January 24, 2025. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.5 mg/0.5 ml pens, with a ceiling value of $3,923.07 and a period of performance through March 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
The Department of Defense's Defense Logistics Agency awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide WEGOVY 0.5 mg/0.5 ml pens. The contract has a completion date of February 2, 2024 and a potential value of $1,097.08. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 2.4 mg/0.75 ml pens with a ceiling value of $1,021.78 and a period of performance through January 28, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation noted. AmerisourceBergen Drug Corp. has an extensive Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $3,451.92 and is a firm fixed-price delivery order with an ultimate completion date of April 1, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1.7 mg/0.75 ml pens. The contract has a Firm Fixed Price pricing type and a ceiling value of $18,376.06. The ultimate completion date is April 2, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEF35
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of WEGOVY 2.4 mg/0.75 ml pens. The contract has a ceiling value of $3,562.38 and an ultimate completion date of November 14, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 2:20 PM